PureTech Health (PRTC) Other Gross PP&E Adjustments (2023 - 2025)
PureTech Health (PRTC) reported Other Gross PP&E Adjustments of -$7.2 million for Q2 2025, up 10.94% on a QoQ basis from -$8.1 million in Q4 2024.
PureTech Health (PRTC) has 3 years of Other Gross PP&E Adjustments data on file, last reported at -$7.2 million in Q2 2025.
- Quarterly Other Gross PP&E Adjustments changed N/A year-over-year to -$7.2 million in Q2 2025, while the trailing twelve-month figure through Jun 2025 was -$7.2 million (changed N/A YoY) and the FY2024 annual result came in at -$8.1 million, down 182.05% from the prior year.
- Other Gross PP&E Adjustments climbed to -$7.2 million in Q2 2025 per PRTC's latest filing, from -$8.1 million in the prior quarter.
- Across five years, Other Gross PP&E Adjustments topped out at $9.8 million in Q4 2023 and bottomed at -$8.1 million in Q4 2024.
- The 3-year median for Other Gross PP&E Adjustments is -$7.2 million (2025), against an average of -$1.8 million.
- Peak annual rise in Other Gross PP&E Adjustments reached 182.05% in 2024, while the deepest fall reached 182.05% in 2024.
- Tracing PRTC's Other Gross PP&E Adjustments over 3 years: stood at $9.8 million in 2023, then plunged by 182.05% to -$8.1 million in 2024, then gained by 10.94% to -$7.2 million in 2025.
- Per Business Quant, the three latest PRTC Other Gross PP&E Adjustments figures stand at -$7.2 million (Q2 2025), -$8.1 million (Q4 2024), and $9.8 million (Q4 2023).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Gross PP&E Adjustments (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,384,976.65 Bn | 1,384,976.64 Bn | - | -83,048.00 |
| 2 | Alterity Therapeutics | 777,208.84 Bn | 777,208.81 Bn | - | -60,691.22 |
| 3 | Legend Biotech | 2,801.00 Bn | 2,800.10 Bn | 242.10 Mn | -285.20 Mn |
| 4 | Nanobiotix | 2,226.01 Bn | 2,225.95 Bn | - | - |
| 5 | Akari Therapeutics | 605.66 Bn | 605.66 Bn | - | -892,000.00 |
| 6 | Vertex Pharmaceuticals | 110.17 Bn | 102.92 Bn | 2.59 Bn | -1.69 Bn |
| 7 | Regeneron Pharmaceuticals | 66.86 Bn | 58.11 Bn | 3.31 Bn | - |
| 8 | Evaxion A | 65.12 Bn | 65.10 Bn | - | - |
| 9 | Alnylam Pharmaceuticals | 39.94 Bn | 36.94 Bn | 959.66 Mn | -189.30 Mn |
| 10 | PureTech Health | 86.36 Mn | -190.94 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | -7.18 Mn |
| Jun 30, 2025 | -7.18 Mn |
| Dec 31, 2024 | -8.06 Mn |
| Dec 31, 2024 | -8.06 Mn |
| Dec 31, 2023 | 9.83 Mn |
| Dec 31, 2023 | 9.83 Mn |